Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survival. 1984

C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli

To investigate the value of maintenance chemotherapy after early consolidation treatment, an attempt was made to induce remission in 162 previously untreated patients, age-range 7-65 years (median 43). The 74 patients who were still in remission after early consolidation treatment (given for 3-5 months) were assigned to either maintenance chemotherapy every 8 weeks for 2 years or to observation only. After a median observation period of 44 months there was no difference between the groups in duration of remission or survival. Surprisingly, patients above 40 survived longer after early consolidation (median 4 years) than did patients aged 40 and below (median 1.6 years, p = 0.0002).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness

Related Publications

C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
October 1986, Cancer,
C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
April 1984, Lancet (London, England),
C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
January 1991, Bailliere's clinical haematology,
C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
September 2003, Best practice & research. Clinical haematology,
C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
March 1980, British journal of cancer,
C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
October 1972, Journal of the Irish Medical Association,
C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
May 1981, British medical journal (Clinical research ed.),
C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
July 1981, British medical journal (Clinical research ed.),
C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
September 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
C Sauter, and W Berchtold, and M Fopp, and A Gratwohl, and P Imbach, and P Maurice, and L Tschopp, and V von Fliedner, and F Cavalli
January 1999, Ophthalmic research,
Copied contents to your clipboard!